Chemoembolisation des hepatozellulären Karzinoms: Welche Faktoren bestimmen Therapieansprechen und Überleben?

Ziel Methodik: Ergebnisse: Schlussfolgerung: Purpose: Materials and Methods Results: Conclusions:

[1]  J. Lois,et al.  Comparison of transarterial chemoembolization in patients with unresectable, diffuse vs focal hepatocellular carcinoma. , 2002, Archives of surgery.

[2]  John Wong,et al.  Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma , 2002, Hepatology.

[3]  H. Ueno,et al.  Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. , 2001, AJR. American journal of roentgenology.

[4]  W. M. Lam,et al.  A randomized clinical trial comparing autologous blood clot and gelfoam in transarterial chemoembolization for inoperable hepatocellular carcinoma. , 2000, Journal of hepatology.

[5]  J. Bruix,et al.  Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution , 1998, Hepatology.

[6]  Y. Yamashita,et al.  Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management. , 1995, Radiology.

[7]  M. Biselli,et al.  Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian Experience , 1995, Cancer.

[8]  K. Tanikawa,et al.  Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The liver cancer study group of japan , 1994, Cancer.

[9]  K. Boudjema,et al.  Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4‐year Study of 127 French Patients , 1994, Cancer.

[10]  C. Claussen,et al.  Chemoembolisation des hepatozellulären Karzinoms: Computertomographische Befunde und klinische Resultate bei prospektiv repetitiver Therapie , 1994 .

[11]  G. Idéo,et al.  Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: A multivariate analysis of prognostic factors , 1994, Hepatology.

[12]  H. Abo,et al.  [Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization (TAE)--significance of repetitive therapies and responses to them within 6 months after the first intervention]. , 1993, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

[13]  M. Okazaki,et al.  Hepatocellular carcinoma: a multivariate analysis of prognostic features in patients treated with hepatic arterial embolization. , 1992, The American journal of gastroenterology.

[14]  L. Bolondi,et al.  Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival , 1992, Hepatology.

[15]  Kenji Ikeda,et al.  Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the cox proportional hazard model , 1991, Cancer.

[16]  Kyoichi Inoue,et al.  Prognosis of unresectable hepatocellular carcinoma: An evaluation based on multivariate analysis of 90 cases , 1991, Hepatology.

[17]  Y. Yamashita,et al.  Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion , 1991, Cancer.

[18]  J. Bruix,et al.  Prognostic factors of hepatocellular carcinoma in the west: A multivariate analysis in 206 patients , 1990, Hepatology.

[19]  A. Roche,et al.  A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. , 1990, Journal of hepatology.

[20]  H. Hasegawa,et al.  Hepatic artery embolization for inoperable hepatocellular carcinoma; prognosis and Risk Factors , 2004, Cancer Chemotherapy and Pharmacology.

[21]  Michio Kato,et al.  Analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization , 2004, Cancer Chemotherapy and Pharmacology.

[22]  Sheng-Nan Lu,et al.  Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization and analysis of prognostic factors , 2004, Cancer Chemotherapy and Pharmacology.

[23]  B. Carr.  Hepatic artery chemoembolization for advanced stage HCC: experience of 650 patients. , 2002, Hepato-gastroenterology.

[24]  J. Figueras,et al.  A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization , 2000, Cancer.

[25]  O. Ernst,et al.  Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response. , 1999, AJR. American journal of roentgenology.

[26]  M. Rinaldi,et al.  Unresectable hepatocellular carcinoma in cirrhosis , 1996, Digestive Diseases and Sciences.